Skip to main content

Table 1 Demographic, clinical and histological characteristics of the samples

From: Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development

Characteristics

Diseased

Healthy

P-value

n

12

14

Age (years) mean ± SD

68.0 ± 10.81

61.14 ± 11.2

0.11

Ethnicity

   

Asian, Pacific Islander

0

1

 

White, non-Hispanic

4

2

 

Black, non-Hispanic

4

4

 

Hispanic

1

3

 

Other and unknown

3

4

 

Height (cm) mean ± SD

165 ± 8.69

166.5 ± 8.63

0.6

Weight (kg) mean ± SD

78.0 ± 22.02

88.32 ±15.93

0.2

BMI (kg/m2) mean ± SD

27.85 ± 6.41

31.25 ± 5.58

0.18

Diabetes

6

5

 

Hypertension

11

12

 

Proteinuria (dipstick)

3.0 ± 1.83

0.36 ± 0.81

1.80E-04

Serum BUN (mg/dL) mean ± SD

35.0 ± 14.7

17.71 ±5.85

4.60E-04

Serum creatinine (mg/dL) mean ± SD

3.0 ± 1.61

1.08 ± 0.18

2.00E-03

eGFR (ml/minute/1.73 m2) mean ± SD

29.0 ± 13.68

70.94 ± 8.35

1.06E-09

Histology

   

Glomerulosclerosis (%)

31.0 ± 31.35

3.31 ±5.52

4.00E-03

Mesangial matrix expansion

1 ± 0.91

0.17 ± 0.39

0.03

Tubular atrophy (%)

34.0 ± 24.94

9.82 ± 15.76

6.00E-03

Interstitial fibrosis (%)

34.0 ± 25.15

5.68 ± 5.07

4.00E-04

Vascular sclerosis

   

Intima

2.0 ± 0.78

0.9 ± 1.1

1.50E-03

Arterioles

2.0 ± 0.78

0.29 ± 0.62

4.00E-04

  1. eGFR, estimated glomerular filtration rate; SD, standard deviation.